Evaluation of direct E-test on lower respiratory tract samples: a rapid and accurate procedure for antimicrobial susceptibility testing

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 2, 2007, Pages 211-216

  Cercenado, Emilia ^a   Cercenado, Sonia ^a   Marín, Mercedes ^a   Rico, María Victoria ^a   Vicente, Teresa ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

E test; ICU; Rapid susceptibility testing; Respiratory samples; Ventilator associated pneumonia

Indexed keywords

AGAR; AMIKACIN; CEFEPIME; CIPROFLOXACIN; IMIPENEM; MUELLER HINTON AGAR; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; COLONY FORMING UNIT; CULTURE MEDIUM; DEVICE; DILUTION; EVALUATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; MICROBROTH DILUTION METHOD; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPAIN; STANDARD;

COLONY COUNT, MICROBIAL; HUMANS; LUNG; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, VENTILATOR-ASSOCIATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 34249812083     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.12.021     Document Type: Article

References (30)

1. Barreiro-López B., Tricas J.M., Mauri E., Quintana S., and Garau J. Risk factors and prognostic factors in nosocomial pneumonia outside the intensive care units setting. Enferm. Infecc. Microbiol. Clin. 23 (2005) 519-524
2. Blot F., Raynard B., Chachaty E., Tancrede C., Antoun S., and Nitenberg G. Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am. J. Respir. Crit. Care Med. 162 (2000) 1731-1737
3. Bolmström A., Arvidson S., Ericsson M., and Karlsson A. A novel technique for direct quantification of antimicrobial susceptibility of microorganisms. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, USA (1988) (Abstract 1209)
4. Bouza E., Torres M.V., Radice C., Cercenado E., Muñoz P., de Diego R., and Sánchez C. Direct E-test on lower respiratory tract samples: improving antimicrobial use in ventilator-associated pneumonia. 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice (France) (2006) (Abstract P1436)
5. Cavalcanti M., Valencia M., and Torres A. Respiratory nosocomial infections in the medical intensive care unit. Microbes Infect. 7 (2005) 292-301
6. Chang H.C., Chang J.J., Chan S.H., Huang A.H., Wu T.L., Lin M.C., and Chang T.C. Evaluation of E-test for direct antifungal susceptibility testing of yeasts in positive blood cultures. J. Clin. Microbiol. 39 (2001) 1328-1333
7. Chastre J., and Fagon J.Y. Ventilator-associated pneumonia. State of the art. Am. J. Respir. Crit. Care Med. 165 (2002) 867-903
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. M100-S16. Vol. 26 No 3 (2006), CLSI, Wayne, PA
9. Craig C.P., and Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am. J. Infect. Control 12 (1984) 233-238
10. Cunha B.A. Nosocomial pneumonia. Diagnostic and therapeutic considerations. Med. Clin. North Am. 85 (2001) 79-114
11. Doern G.V., Vautour R., Gaudet M., and Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32 (1994) 1757-1762
12. Dupont H., Mentec H., Sollet J.P., and Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 27 (2001) 355-362
13. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., and Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 94 (1993) 281-288
14. Fagon J.Y., Chastre J., Vuagnat A., Trouillet J.L., Novara A., and Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275 (1996) 866-869
15. Hong T., and Ndamukong J. Direct application of E-test to Gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data. Diagn. Microbiol. Infect. Dis. 25 (1996) 21-25
16. Huang M., Baker P.N., Banerjee S., and Tenover F.C. Accuracy of the E-test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and Gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30 (1992) 3243-3248
17. Kollef M.H. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. Respir. Care 49 (2004) 1530-1541
18. Laupland K.B., Church D.L., and Gregson D.B. Validation of a rapid diagnostic strategy for determination of significant bacterial counts in bronchoalveolar lavage samples. Arch. Pathol. Lab. Med. 129 (2005) 78-81
19. Macias E.A., Mason Jr. E.O., Ocera H.Y., and LaRocco M.T. Comparison of E-test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J. Clin. Microbiol. 32 (1994) 430-432
20. Marquette C.H., Georges H., Wallet F., Ramon P., Saulnier F., Neviere R., Mathieu D., Rime A., and Tonnel A.B. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am. Rev. Respir. Dis. 148 (1993) 138-144
21. Mehta R.M., and Niederman M.S. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J. Intensive Care Med. 18 (2003) 175-188
22. Pinner R.W., Haley R.W., Blumenstein B.A., Schaberg D.R., Von Allmen S.D., and McGowan J.E. High cost nosocomial infections. Infect. Control 3 (1982) 143-149
23. Rello J., Vidaur L., Sandiumenge A., Rodríguez A., Gualis B., Boque C., and Díaz E. De-escalation therapy in ventilator-associated pneumonia. Crit. Care Med. 32 (2004) 2183-2190
24. Safdar N., Dezfulian C., Collard H.R., and Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit. Care Med. 33 (2005) 2184-2193
25. Shulman L., and Ost D. Managing infection in the critical care unit: how can infection control make the ICU safe?. Crit. Care Clin. 21 (2005) 118-128
26. Simor A.E., Goswell G., Louie L., Lee M., and Louie M. Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and E-test. Eur. J. Clin. Microbiol. Infect. Dis. 16 (1997) 693-697
27. Torres A., Aznar R., Gatell J.M., Jiménez P., Gonzalez J., Ferrer A., Celis R., and Rodriguez-Roisin R. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142 (1990) 523-528
28. Trenholme G.M., Kaplan R.L., Karakusis P.H., Stine T., Fuhrer J., Landan W., and Levin S. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J. Clin. Microbiol. 27 (1989) 1342-1345
29. York M.K., and Gilligan P. Lower respiratory tract cultures. In: Isenberg H.D. (Ed). Clinical Microbiology Procedures Handbook. 2nd ed. (2004), ASM Press, Washington, DC 3.11.2.1-3.11.2.12
30. Zebouh M., Thomas C., Honderlick P., Lemee L., Segonds C., Wallet F., and Husson M.O. Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis. Pathol. Biol. 53 (2005) 490-494